N/A
N=388
Efficiency of the King Vision Video Laryngoscope
Respiratory Failure · Intubation
Bottom Line
View on ClinicalTrials.gov: NCT02482870 ↗Enrolled (actual)
388
Serious AEs
0.0%
Results posted
Feb 2018
Primary outcome: Primary: Intubation Success Rate — 22; 13; 366; 375 participants — p=0.119
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Macintosh laryngoscope (Device); King Vision video laryngoscope (Device)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Recep Tayyip Erdogan University
- Primary completion
- Jul 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Intubation Success Rate |
22; 13; 366; 375 | 0.119 |
| SECONDARY Intubation Time |
6.6; 10.8 | <0.0001 sig |
| SECONDARY Glottic View Time |
7.3; 7.9 | <0.0001 sig |
| SECONDARY Cormack-Lehane Score |
149; 357; 139; 31; 93; 0 | <0.0001 sig |
| SECONDARY Airway Complications |
384; 382; 4; 6 | 0.75 |
Summary
The investigators studied the efficiency of Macintosh laryngoscope and the King Vision video laryngoscope in adult patients scheduled for general anesthesia. Best Cormack-Lehane score obtained, glottic view time, intubation time, time to ventilation, correlation between the Mallampati classification and the Cormack-Lehane grades, and complications related to laryngoscopy and intubation has been investigated.
Eligibility Criteria
Inclusion Criteria
- scheduled for general anesthesia
- age higher than 18 years
- age lower than 60 years
Exclusion Criteria
- emergency surgery
- mouth opening less than 2 cm
- American Society of Anesthesiologists (ASA) score higher than 2
- oropharyngeal anomaly
- glottic or supraglottic mass
- history of surgery due to oropharyngeal anomaly, glottic or supraglottic mass
Data sourced from ClinicalTrials.gov (NCT02482870). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.